To experimental arm randomly assigned, HPC-03 will administrated twice a day , two capsules each time (total dose of HPC-03: 2g/day) for 12 weeks (84days).
*(HPC-03: extracts of angelica gigas nakai, cnidium rhizome, and cinnamon bark.)

To control arm randomly assigned, placebo will administrated twice a day , two capsules each time for 12 weeks (84days).

Postmenopausal Period

HPC-03 is extracts of danggui (angelica gigas nakai), taeunggung (cnidium rhizome), and broilers (cinnamon bark).

HPC-03

Placebo is constituted of crystalline cellulose(50.5%), corn starch(33.10%), caramel color(1.90%), anhydrous citric acid(1.25%), silicon dioxide(1.90%), carboxymethylcellulose calcium(6.25%), magnesium stearate(2.50%), and coater (3.10%).

Placebo

Severance hospital, Yonsei University College of Medicine

Efficacy and Safety of HPC-03 for Postmenopausal Symptom

Efficacy and Safety of HPC-03(Extracts of Angelica Gigas Nakai, Cnidium Rhizome, and Cinnamon Bark) for Postmenopausal Symptom

Jae Hoon Lee

Cinical Fellow

Gachon University Gil Medical Center

Daejeon University

This clinical trial will be conducted in parallel with the test group or the control group randomly assigned.

The product manufactured as clinical food and placebo are identical in shape, color and weight. In addition, clinical trial food should be labeled by affixing the same label with placebo so that it remains blind to both subjects and the investigator. Lot number of the label, includes reference number of the test food and reference number of the placebo together.
Dispensing of food and placebo for clinical trials is handled by the management pharmacist.
Clinical tester supplies clinical trial food corresponding the random assignment code assigned to subjects. Except inevitable cases such as occurrence of adverse events resulted by clinical food, the code will not be released until the end of the clinical trial. In case of deficiency or breakage of food for clinical trial, extra clinical food with unique code will provided to subjects, therefore maintain blinding.

angelica biserrata/phosphatase

Efficacy and Safety of HPC-03 for Postmenopausal Symptom

Najkompletnija baza ljekovitog bilja potpomognuta znanošću